The effect of FK506 on transforming growth factor β signaling and apoptosis in chronic lymphocytic leukemia B cells

Simona Romano, Maria Mallardo, Federico Chiurazzi, Rita Bisogni, Anna D'Angelillo, Raffaele Liuzzi, Giovanna Compare, Maria Fiammetta Romano

Research output: Contribution to journalArticlepeer-review

Abstract

Background Loss of response to transforming growth factor-beta (TGF-β) is thought to contribute to the progression of chronic lymphocytic leukemia. Recent findings of over-activation of the TGF-β signal in FKBP12-knockout mouse prompted us to investigate whether FK506, the canonical ligand of FKBR can activate the TGF-β signal in chronic lymphocytic leukemia. Design and Methods We studied 62 chronic lymphocytic leukemia samples from patients with Rai/Binet stage 0 to 4 disease. The TGF-β signal was investigated by western blotting and flow eytometry. The levels of Bc12-family members and death-associated-protein kinase were also investigated by western blotting, whereas apoptosis was studied in flow cytometry. Down-modulation of FKBP12 was obtained by gene silencing with short interfering RNA. Results Twenty-two out of 62 chronic lymphocytic leukemia samples were sensitive to TGF-β-induced apoptosis. All but two of the responsive samples underwent apoptosis also when cultured with FK506, but not with cyclosporine. Thirteen samples that were not sensitive to TGF-β were sensitive to FK506. Overall, response to FK506 occurred in 33 samples. FK506 induced Smad2 phosphorylation and nuclear translocation. Accordingly, death-associated-protein kinase, a transcriptional target of Smad, was induced. At the same time, Bcl-2 and Bcl-xL levels decreased whereas the levels of Bim and Bmf increased. A loss of mitochondrial membrane potential preceded caspase activation and cell death. FK506 removed FKBP12 from its binding to the TGF-β-receptor. FKBP12 release activated the receptor-kinase activity as suggested by the enhanced levels of phospho-Smad found in cells depleted of FKBP12. Conclusions Our study shows that most chronic lymphocytic leukemia cells escape the homeostatic control of TGF-β and that FK506 restores the TGF-β signal in a proportion of non-responsive samples. We demonstrated that FK506 activates TGF-β receptor I kinase activity in chronic lymphocytic leukemia, which transduces apoptosis by a mitochondrial-dependent pathway.

Original languageEnglish
Pages (from-to)1039-1048
Number of pages10
JournalHaematologica
Volume93
Issue number7
DOIs
Publication statusPublished - Jul 2008

Keywords

  • Apoptosis
  • Chronic lymphocytic leukemia
  • FK506
  • TGF-β

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'The effect of FK506 on transforming growth factor β signaling and apoptosis in chronic lymphocytic leukemia B cells'. Together they form a unique fingerprint.

Cite this